Deal News

  • 17 April 2019

    Gilead and insitro team up to develop treatment for NASH

    Gilead Sciences has partnered with insitro, a data-driven drug discovery startup, to leverage an artificial intelligence based platform for the discovery and development of new drugs to treat nonalcoholic steatohepatitis.

Go Top